Editorial: Reviews in neurogenetics - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Editorial: Insights into Neurogenetic Research Reviews

  • By

  • Lucia F. Cardo

  • September 14, 2026

Share

Objective:

To review contributions to the Research Topic 'Reviews in neurogenetics' published in Frontiers in Neurology and highlight advancements in diagnosing and treating neurogenetic disorders.

Approach:
  • Clinical trials in Charcot-Marie-Tooth Disorders: Nair et al. conducted a retrospective analysis of clinical trials from 1999 to 2022, noting a significant increase in trials focused on procedural and targeted gene therapies, with most trials hosted in academic settings.
  • Neuroimaging in PRUNE1 syndrome: Scorrano et al. reviewed the clinical and radiological features of PRUNE1 syndrome, emphasizing the importance of neuroradiological features for diagnosis.
  • Genetic blueprints of neurological disorders: Saeed et al. provided a comprehensive review of genetic bases for various neurological disorders and discussed the potential of RNA-based therapeutics and gene therapies.
  • Clinical and genetic analysis of cerebrotendinous xanthomatosis: Guoliang et al. investigated a Chinese family with CTX, identifying genetic variants and broadening the understanding of CTX's clinical spectrum.
Key Findings:
  • Substantial growth in clinical trials for Charcot-Marie-Tooth disorders, primarily in academic settings.
  • Identification of key neuroradiological features in PRUNE1 syndrome that aid in diagnosis.
  • Potential of RNA-based therapeutics and gene therapies highlighted in the context of neurological disorders.
  • Discovery of specific genetic variants in cerebrotendinous xanthomatosis that enhance diagnostic understanding.
Interpretation:

The editorial emphasizes the need for continued research and application of comparable approaches across various neurogenetic disorders.

Limitations:
  • Limited representation of less common neurogenetic disorders in current research.
  • Potential biases in the retrospective analysis of clinical trials.
Conclusion:

The editorial calls for further integration of genetic investigations, therapeutic approaches, and neuroimaging to advance understanding and treatment of neurogenetic disorders.

Sources:

Original Source(s)

Related Content